X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (418) 418
Publication (47) 47
Book Chapter (4) 4
Conference Proceeding (3) 3
Government Document (2) 2
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (196) 196
male (168) 168
female (123) 123
aged (116) 116
middle aged (79) 79
neurosciences (78) 78
adult (74) 74
psychiatry (72) 72
index medicus (69) 69
alzheimer's disease (46) 46
clinical neurology (44) 44
animals (43) 43
aged, 80 and over (40) 40
norepinephrine (39) 39
neurology (38) 38
alzheimers-disease (37) 37
article (36) 36
brain (36) 36
ptsd (36) 36
prazosin (35) 35
dementia (34) 34
veterans (33) 33
aging (32) 32
rats (29) 29
alzheimer disease - genetics (28) 28
alzheimer disease - psychology (24) 24
geriatrics & gerontology (24) 24
adults (21) 21
genotype (21) 21
post-traumatic stress disorder (20) 20
research (20) 20
treatment outcome (20) 20
alzheimer disease (19) 19
endocrinology & metabolism (19) 19
norepinephrine - blood (19) 19
alzheimer disease - pathology (18) 18
neurons (18) 18
risk factors (18) 18
americans (17) 17
double-blind (17) 17
prazosin - therapeutic use (17) 17
psychiatric status rating scales (17) 17
abridged index medicus (16) 16
alzheimer disease - cerebrospinal fluid (16) 16
alzheimer disease - diagnosis (16) 16
alzheimers disease (16) 16
antiadrenergic agents (16) 16
brain - metabolism (16) 16
senile dementia (16) 16
stress disorders, post-traumatic - psychology (16) 16
treatment effectiveness (16) 16
alzheimer disease - physiopathology (15) 15
analysis (15) 15
brain - pathology (15) 15
cerebrospinal fluid (15) 15
cortisol (15) 15
double-blind method (15) 15
hippocampus (15) 15
hydrocortisone - blood (15) 15
stress (15) 15
adrenergic alpha-antagonists - therapeutic use (14) 14
age (14) 14
aging - physiology (14) 14
blood pressure - drug effects (14) 14
genetics (14) 14
memory (14) 14
psychology, clinical (14) 14
risk (14) 14
vasopressin (14) 14
alzheimer disease - drug therapy (13) 13
in situ hybridization (13) 13
neuropsychological tests (13) 13
symptoms (13) 13
apolipoproteins e - genetics (12) 12
case-control studies (12) 12
combat veterans (12) 12
galanin (12) 12
genetic predisposition to disease (12) 12
messenger-rna (12) 12
sleep (12) 12
alzheimer disease - metabolism (11) 11
comorbidity (11) 11
depression (11) 11
epinephrine - blood (11) 11
males (11) 11
medicine, general & internal (11) 11
nightmares (11) 11
norepinephrine - cerebrospinal fluid (11) 11
polymorphism, single nucleotide (11) 11
posttraumatic stress disorder (11) 11
posttraumatic-stress-disorder (11) 11
rat-brain (11) 11
severity of illness index (11) 11
stress disorders, post-traumatic - drug therapy (11) 11
veterans - psychology (11) 11
young adult (11) 11
acth (10) 10
adrenocorticotropic hormone - blood (10) 10
alzheimer disease - blood (10) 10
care and treatment (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Medicine, ISSN 0002-9343, 11/2008, Volume 121, Issue 11, pp. S28 - S37
Depression is common in patients with neurologic disorders such as Alzheimer disease, stroke, Parkinson disease, and multiple sclerosis. Diagnosing depression... 
Multiple sclerosis | Stroke | Alzheimer disease | Antidepressants | Parkinson disease | Depression
Journal Article
Lancet Neurology, ISSN 1474-4422, 2012, Volume 11, Issue 3, pp. 241 - 249
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article